Occupy the USDOJ protest June 1 through July 4

Facebook page:

https://www.facebook.com/photo.php?fbid=10206244369375477&set=a.3372263992710.152352.1452595099&type=1

 

Society for Advancement of Scientific Hermeneutics (SASH)

 

FOR IMMEDIATE RELEASE

https://badlymeattitude.files.wordpress.com/2015/05/chargescomplete.pdf

 

May 17, 2015

 

Washington, D.C., May 17, 2015: Medical abuse-victims' rights group Society for Advancement of Scientific Hermeneutics (SASH), announces its Occupy the USDOJ protest beginning June 1, in Washington, D.C. This Occupy movement, led by a group of chronically ill and disabled activists, is a direct result of the medical abuse they say has been inflicted upon them by government and the medical/pharmaceutical corporate complex.

 

The Occupy leaders state in their criminal charge sheets that there is a common disease mechanism linking Lyme disease, ME/CFS, Gulf War Illness, Fibromyalgia and Autism. Furthermore, to expose such mechanism would reveal rampant fraud and racketeering within the CDC and other entities, as well as the cause of the autism pandemic. All abused patient groups are encouraged to join this peaceful but passionate protest on the steps of USDOJ,950 Pennsylvania Ave NW, Washington,DC, USA , from June 1 until July 4.

 

Through a massive compilation of published scientific research and public-record documents, SASH makes a convincing case for Lyme Disease, ME/CFS, Gulf War Illness, Fibromyalgia and Autism sharing a common mechanism of fungal-induced immunosuppression, known to the National Institutes of Health (NIH) as "PostSepsis Syndrome." They report that such immunosuppression leads to the chronic reactivation in the central nervous system of multiple viruses such as Epstein-Barr Virus, Cytomegalovirus and HHV-6, leading to cancers and an AIDS-like disease. SASH also shares evidence that the interaction of fungi with attenuated viruses in vaccine vials causes the reactivation of those viruses and ultimately, the diseases they are meant to prevent.

 

The group's primary charge centers on the USDOJ's failure to take action on a whistleblower complaint that was filed in July 2003 by Kathleen Dickson, a former analytical chemist at pharmaceutical giant Pfizer. Her complaint alleged that CDC officers, Yale University medical faculty and others committed research fraud to falsify the current, Dearborn case definition (2-tiered test standard) in order to falsify the outcomes of the OspA vaccines, namely LYMErix, which was pulled from the market after an FDA ultimatum to the manufacturer.

 

Ms. Dickson's complaint further alleged that the very same government employees who committed these crimes stood to gain substantial financial rewards from a monopoly on all tick-borne diseases, vaccines and test kits. Additionally, their falsification of the Lyme disease case definition and treatment guidelines have left 85% of actual Lyme sufferers unable to obtain diagnosis, treatment, or insurance coverage for their AIDS-and cancer-like illness.

 

An abundance of scientific and historical evidence is presented in the charge sheets. Many of the citations refer to the alleged criminals' own peer-reviewed, published research papers and patent documents, which paint a chilling picture of the extreme effort that SASH says has been made by the alleged criminals to deny basic healthcare to an estimated 30 million sufferers in the United States. They say that the extent of deceit and corruption, with intent to deny an illness, goes far beyond anything that occurred in the early days of AIDS activism.

 

They are calling on USDOJ to prosecute for the fraud and racketeering charges, which have left millions of people to suffer in isolation while being ridiculed by doctors, family members and employers as psychosomatic or lazy. The victims, often bankrupted by the high cost of out-of-pocket medical expenses, and unable to work due to illness, frequently commit suicide to escape their continuous denial of basic human rights.

 

For additional information and to view the charge sheets, visitwww.ohioactionlyme.org

 

February 7th, 2015 / gman211999

1. ALDF-CDC Enterprise Conspires to Defraud USA in Dearborn-Vaccine Scam

2. Lyme Disease Patents

3. Lyme Disease Biomarkers

4. Patient's Guide to NIH's Post Sepsis Syndrome

5. Primers Shell Game

6. The Common Mechanisms of Fungal-Viral Damage in CFIDS, Vaccines-Autism, and "Chronic Lyme"/New Great Imitator, per the CDC , NIH and IDSA

7. State of CT and Yale assaulted Czech children

8. Simon Wessely and the abuse of Gulf War veterans, Justina Pelletier and 21st century witch trials

Upcoming radio show about Lyme disease - July 8, 2015

It's Lyme Disease Season: What To Know About Contracting, Diagnosing And Treating The Disease -

The Diane Rehm Show http://thedianerehmshow.org/shows/2015-07-08/its-lyme-disease-season-what-to-know-about-contracting-diagnosing-and-treating-the-disease  

Around 300,000 people contract the tick borne disease every year. We discuss what you should know about contracting, diagnosing and treating Lyme disease.

This should be an interesting show.  Neil Spector, author of "Gone In A Heartbeat: A Physician's Search For True Healing," and Dr. John Aucott should have some interesting commentary. 

Dr. Spector's heart was so badly damaged by Lyme disease that a heart transplant was required to save his life. Dr. Aucott is a leading researcher, whose groundbreaking SLICE study focuses on the realities of treating chronic Lyme patients.  

Around 300,000 new cases of Lyme Disease are reported every year. And experts say the areas the tick borne disease is found is expanding. An update on contracting, diagnosing and treating Lyme disease.

Guests

• Dr. John Aucott director, Lyme Disease Clinical Research Center at the Johns Hopkins Bayview Medical Center. He is the president of the Lyme Disease Research Foundation. 
• Dr. Sunil Sood chairman of pediatrics, Southside Hospital North Shore-LIJ Health System; attending, Infectious Diseases at Cohen Children's Medical Center of New York; professor of pediatrics and family medicine, Hofstra North Shore-LIJ School of Medicine.           
• Paul Roepe co-director, the Center for Infectious Disease at Georgetown University; professor of chemistry at Georgetown University Medical Center. 
•  Dr. Neil Spector author, "Gone In A Heartbeat: A Physician's Search For True Healing". He is associate professor for the departments of medicine and pharmacology and cancer biology at the Duke University School of Medicine.

Australia (slowly) beginning a conversation about Lyme

An investigation into the existence of Lyme disease across Australia will be debated in State Parliament before the end of the year with Maitland MP Jenny Aitchison calling for the ­government to consider recognition of the illness.

With the debate surrounding the controversial tick-borne illness ­gathering momentum, Ms. Aitchison has moved a three-point motion ­imploring the government to listen to the plight of sufferers.   

Read the rest of the story:

http://www.maitlandmercury.com.au/story/3169546/maitland-mp-to-take-lyme-disease-battle-to-state-parliament/

Lyme bill passes in Maine!

https://m.facebook.com/story.php?story_fbid=10203935924393069&id=1670790216

Today, LD422, An Act To Improve Access to Treatments for Lyme Disease, silently passed into law. The Governor took no action on it and it has passed its required waiting period since Enactment by the House and Senate. Yes, indeed, it is law. It still needs to wait its required 90 days from the adjournment of the Legislature before it fully takes effect.

I want you to fully absorb what this means. The very first time we introduced a doctor protection bill in Maine, this group was able to shepherd that bill through Committee (boy, was that a battle), through the House, and through the Senate with overwhelming victories in both bodies of the Legislature. 

The Legislative Working Group, made up of 8 women from around the state, along with tremendous help from our bill's primary sponsor, Rep. Deb Sanderson, a tremendous idea from Rep. Ryan Michael Fecteau, in consultation with Rep. Sanderson, to get the bill out of Committee, and with help from our lobbyist friend, Bill Whitten, passed this bill into law by overcoming MaineHealth (the Maine consortium of hospitals), Maine Medical Association (loosely speaking, Maine doctors "union"), Infectious Disease doctors in Maine (effectively, IDSA of Maine) and Maine Board of Licensure in Medicine. We appreciate all the contact that the public made with your legislators. You most certainly made a difference. 

Today, David beat Goliath!

-The Legislative Working Group

Here is the language that was in the final draft.......ND's, PA's and NP's were negotiated out of the language.

http://www.mainelegislature.org/legis/bills/getPDF.asp?paper=HP0289&item=4&snum=127

2. Lyme disease treatment. A physician licensed under this chapter may prescribe, administer or dispense long-term antibiotic therapy for a therapeutic purpose to eliminate infection or to control a patient's symptoms upon making a clinical diagnosis that the patient has Lyme disease or displays symptoms consistent with a clinical diagnosis of Lyme disease. The physician shall document the clinical diagnosis and treatment in the patient's medical record. The clinical diagnosis must be based on knowledge obtained through medical history and physical examination only or in conjunction with testing that provides supportive data for the clinical diagnosis.

How To Get Rid of Bugs & Pests

A list of various pests (bed bugs, snakes, chiggers, fruit flies, ticks and more) and how to get rid of them.  Includes some videos on what doesn't work when tested.  Most are DIY projects that are either low-cost or free when using normal household items.  Many are non-toxic and safe for the household and environment.

https://sites.google.com/site/floridalyme/prevention/something-bugging-you

Richard Horowitz on the Today Show

This is the link to the interview with Richard Horowitz on the Today Show:

http://www.today.com/popculture/chronic-lyme-disease-what-you-need-know-1D79878631

 

Air pollution causing Alzheimer's and Parkinson's disease ?

There is a finding that children in Mexico City are developing Alzheimer's and Parkinson's brain pathology due to the air pollution there:

http://www.ncbi.nlm.nih.gov/pubmed/23509683

And here is an article by the same author on how dark chocolate may be able to prevent it:

http://www.ncbi.nlm.nih.gov/pubmed/23986703

Dr Horowitz to be on Today show, June 17, 2015

I was just alerted that:

Dr Horowitz  will be on the NBC Today Show on Wednesday morning (tomorrow) at 10 am EST discussing Lyme disease. Parents magazine will be there with him discussing the warning signs of tick-borne diseases, and how we can protect our families from the spreading risk of tick-borne infections. Hope you can tune in!

-Bob

Widespread Borrelia miyamotoi Tick-borne Fever Found in US

Janis C. Kelly

June 12, 2015

Borrelia miyamotoi disease (BMD), a tick-borne infection that can cause more severe symptoms than Lyme disease, was first reported in the northeastern United States in 2013 but is becoming more common and should be considered in all areas where deer tick–transmitted infections are endemic, according to a case-series published online June 9 in the Annals of Internal Medicine.

The researchers suggest that BMD might be almost as common as human anaplasmosis among tick-exposed patients who present with fevers in the endemic areas, and they recommend that it be included in routine differential diagnosis protocols.

The timing of BMD peak incidence suggests that, unlike the transmission of Lyme disease pathogen Borrelia burgdorferi, the new infection might be transmitted by unfed larval ticks, who acquire it by transovarial transmission from the infected female tick. This has immediate clinical and public health implications.

In an accompanying editorial, Peter J. Krause, MD, from the Yale School of Public Health and Yale School of Medicine, New Haven, Connecticut, and Alan G. Barbour, MD, from the University of California, Irvine, write, "Bites from larval deer ticks have not been considered as a health threat, but this needs to be reevaluated. Larval transmission of B. miyamotoi has implications for checking for ticks and continuing tick precautions even after the risk for Lyme disease has abated."

The case series report was prepared by a research team led by Philip J. Molloy, MD, medical director of IMUGEN, a commercial laboratory that performs specialized testing of clinical specimens for tick-borne diseases. Cases were acutely febrile patients from the northeastern United States who presented to primary care offices, emergency departments, or urgent care clinics and for whom clinicians ordered testing for tick-transmitted infections. Between April 1, 2013, and October 31, 2014, the researchers identified 97 patients whose blood samples contained B miyamotoi DNA. Clinical information was available for 51 of the 97.

Patients Appeared "Toxic," Were Suspected of Having Sepsis

Presenting symptoms typically included fever, myalgia, influenza-like illness, headache, or rash. The authors write, "Patients presented with acute headache, fever, and chills and were often found to have leukopenia, thrombocytopenia, and elevated aminotransferase levels, mimicking human anaplasmosis infection. Patients were commonly described as appearing 'toxic'; more than 50% were suspected of having sepsis, and 24% required hospitalization. The headaches were most commonly described as severe, resulting in head computed tomography scans and spinal taps in 5 patients."

Initial screening used a whole-blood polymerase chain reaction for specific DNA sequences of a number of common tick-borne infections, including BMD. Because there is not yet an established test for BMD, the researchers used a recombinant B miyamotoi glycerophosphodiester phosphodiesterase enzyme-linked immunosorbent assay to detect antibody to B miyamotoi. Interestingly, only 16% of patients (8/51) had a detectably immune response to recombinant B miyamotoi glycerophosphodiester phosphodiesterase during the acute disease phase, but 86% of the case patients for whom convalescent sera (drawn 5 or more days after the beginning of treatment) were available demonstrated seroconversion.

The authors recommend that, in cases where BMD is suspected but the index specimen is negative by polymerase chain reaction, blood samples from the convalescent period should be tested. In this series, two such cases were identified.

Most cases began in July and August. The authors comment, "[O]ur findings suggest that it may not be a rare infection in the northeastern United States. The months during which cases were identified are consistent with transmission of B. miyamotoiby deer ticks. However, unlike acute Lyme disease, the majority of cases occurred in July and August, perhaps suggesting transmission by larval ticks, which have their peak activity during these months.... These considerations should prompt enhanced public education about the need to continue personal protection measures during the late summer, which is usually believed to be a less risky period because the agents of Lyme disease, babesiosis, and human anaplasmosis are not transmitted by larval deer ticks."

Doxycycline Recommended as First-line Treatment of Suspected BMD

Forty of the 51 patients had received 2- to 4-week courses of oral doxycycline, seven had received amoxicillin (including three patients treated with one or two doses of ceftriaxone beforehand), and one received levofloxacin. Symptoms resolved in from 2 days to 1 week in 40 of the 42 patients for whom outcomes information was available.

In the editorial, Dr Krause and Dr Barbour write, "Doxycycline, amoxicillin, and ceftriaxone seem to be effective in alleviating symptoms and preventing complications. Such therapy would also be effective against co-infection with B. burgdorferi. Doxycycline is the preferred initial therapy in patients with suspected B. miyamotoi infection because it effectively treats Lyme disease and human granulocytic anaplasmosis, which may be the cause of illness or co-infection with B. miyamotoi."

Laboratory investigations showed that 14% of the patients with BMD were coinfected with B burgdorferi. The study authors comment that although sera from patients with acute BMD often show reactivity to B burgdorferi on enzyme immunoassay testing, this is rarely confirmed by immunoblot. They write, "This finding is clinically relevant because a patient presenting with an acute 'summer fever' and no rash and testing positive by whole cell antigen serologic test for Lyme disease could actually be infected with B. burgdorferi, B. miyamotoi, or both. However, sera from patients with BMD generally do not react to B. burgdorferi antigens in [immunoglobulin G or immunoglobulin A] tests, which is partly consistent with what has been previously reported for a small number of case patients with BMD."

Since many cases presented in July and August, when transmission by larval ticks is suspected because of their peak activity during these months, the authors conclude that infection with BMD should be considered in areas where deer tick–transmitted infections are endemic.

The study was funded by IMUGEN. Dr Molloy is the paid medical director of IMUGEN. One coauthor has disclosed receiving personal fees from IMUGEN, Immunetics, Meridian Bioscience, and Fuller Laboratories. Five coauthors are employees of, board members of, or own stock in IMUGEN. The other authors, Dr Krause, and Dr Barbour have disclosed no relevant financial relationships.

Ann Intern Med. 2015; Published online June 9, 2015. Article abstract, Editorial extract

Comments

Carl Tuttle

Hudson, NH 03051

Website: New Hampshire Lyme Misdiagnosis

 

Petitions: 

Calling for a Congressional investigation of the CDC, IDSA and ALDF

 

Letter to the Editor, The Lancet Infectious Diseases Published May 2012

How many people are dying from Lyme-caused heart failure?

This is a letter to the editors of a scientific journal. It was CCed to some legislators. The letter was written by Lyme activist Carl Tuttle. I am reposting it here in my blog because I believe the author raises some important questions about the likely underrorting of fatal cases of Lyme carditis (heart failure caused by Lyme infection).  There are also some useful links about Lyme carditis at the bottom.  -Bob

---

Subject: Lyme Carditis, Copyright © 2015 Elsevier Inc.

Infect Dis Clin North Am. 2015 Jun;29(2):255-268. doi: 10.1016/j.idc.2015.02.003.

Lyme Carditis.

Robinson ML1, Kobayashi T2, Higgins Y2, Calkins H3, Melia MT4.

http://www.ncbi.nlm.nih.gov/pubmed/25999222

Copyright © 2015 Elsevier Inc. All rights reserved.

 

May 26, 2015

 

Infectious Disease Clinics

Consulting Editor:
Helen W. Boucher, MD, FIDSA, FACP

 

To the Editors:

 

There are serious concerns regarding a number of comments found in the Johns Hopkins abstract on Lyme Carditis:

 

Johns Hopkins Comment #1 "Lyme disease is a common disease that uncommonly affects the heart."

 

In reference to the Johns Hopkins propaganda piece on Lyme Carditis I would like to call attention to the following studies:

 

In August of 2012 the CDC announced that the number of Lyme disease cases could be off by a factor of ten adjusting the number to 300,000 new cases annually. The results of the 2014 Lyme Carditis study below was based on 30,000 annual cases from 2001-2010 and must also be off by a factor of ten. The numbers presented in this CDC report are not likely to be representative of the true extent of the problem.

 

Update on Lyme Carditis, Groups at High Risk, and Frequency of Associated Sudden Cardiac Death — United States

http://www.medscape.com/viewarticle/834162

 

Here's what the numbers look like when considering the miscalculation over the same nine year period: (2001–2010)

 

18,760 cases of Lyme carditis.

  7,020 died from all causes within a year of Lyme disease diagnosis.

       50 were classified as suspected cases of Lyme carditis–associated mortality.

 

This study also reports 42% of patients had an accompanying erythema migrans (bulls-eye rash). That's substantially less than the CDC's 60%-80% claim as found on the CDC's 2011 Case Definition page:

http://wwwn.cdc.gov/NNDSS/script/casedef.aspx?CondYrID=752&DatePub=1/1/2011%2012:00:00%20AM

 

The following study reports the deaths of three seemingly healthy individuals who dropped dead from Lyme Carditis. It is important to recognize here that the cause of death was only identified due to the fact that the three Lyme patients were potential organ donors otherwise these cases would not have been identified or reported. We have to ask the question, "How many seemingly healthy Lyme patients have donated blood?" (Our blood supply is not screened for Lyme disease)

 

Three Sudden Cardiac Deaths Associated with Lyme Carditis — United States,

December 13, 2013 / 62(49);993-996

http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6249a1.htm

 

Additional study:

 

Lyme disease: A case report of a 17-year old male with fatal Lyme carditis

E. Yoon correspondence, E. Vail, G. Kleinman, P.A. Lento, S. Li, G. Wang, R. Limberger, J.T. Fallon

http://www.ncbi.nlm.nih.gov/pubmed/25864163

 

 Johns Hopkins Comment #2  "Like other manifestations of Lyme disease, carditis can readily be managed with antibiotic therapy and supportive care measures, such that affected patients almost always completely recover."

 

Since we do not have a lab test to gauge treatment failure or success how do we know for certain that those who do not recover aren't dealing with antibiotic resistant infection?

 

There appears to be a deliberate and coordinated downplay of the seriousness of Lyme disease with its life altering consequences. The Johns Hopkins article is no exception to the ongoing deception. 

 

Respectfully submitted,

 

Carl Tuttle

Hudson, NH 03051

Website: New Hampshire Lyme Misdiagnosis

 

Petition: Calling for a Congressional investigation of the CDC, IDSA and ALDF

 

Letter to the Editor, The Lancet Infectious Diseases Published May 2012

 

 

Additional References:

 

1. Undetected Lyme disease nearly killed Duke researcher
http://www.wral.com/lifestyles/healthteam/story/8331364/

 

Fatal Lyme carditis and endodermal heterotopia of the atrioventricular node.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2429516/

 

2. Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium.

http://www.ncbi.nlm.nih.gov/pubmed/4040723

 

3. Lyme borreliosis as a cause of myocarditis and heart muscle disease.

http://www.ncbi.nlm.nih.gov/pubmed/1915460

 

4. Cardiac Lyme disease - case report - A Fatality confirmed with Autopsy PCR study

Postmortem confirmation of Lyme carditis with polymerase chain reaction.

http://umaryland.pure.elsevier.com/en/publications/postmortem-confirmation-of-lyme-carditis-with-polymerase-chain-reaction%2896d9181d-9d52-4fc7-9149-287cd0123f84%29.html

 

5. Unclassified cardiomyopathy or Lyme carditis? A three year follow-up.
http://www.ncbi.nlm.nih.gov/pubmed/23575786